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Molecular Dissection of the Antibody
Response: Opportunities and Needs
for Application in Cattle
Ruben Barroso †, W. Ivan Morrison and Liam J. Morrison*
Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, United Kingdom
Improving understanding of the bovine adaptive immune response would equip
researchers to more efficiently design interventions against pathogens that impact upon
food security and animal welfare. There are features of the bovine antibody response
that differ substantially from other mammalian species, including the best understood
models in the human and mouse. These include the ability to generate a functionally
diverse immunoglobulin response despite having a fraction of the germline gene diversity
that underpins this process in humans and mice, and the unique structure of a subset of
immunoglobulins with “ultralong” HCDR3 domains, which are of significant interest with
respect to potential therapeutics, including against human pathogens. However, a more
detailed understanding of the B cell response and the production of an effective antibody
response in the bovine is currently hampered by the lack of reagents for the B cell lineage.
In this article we outline the current state of knowledge and capabilities with regard to
B cell and antibody responses in cattle, highlight resource gaps, and summarize recent
advances that have the potential to fundamentally advance our understanding of this
process in the bovine host.
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INTRODUCTION
The molecular basis of how antibody repertoires are generated is broadly similar between
mammalian species. Rearrangement of genes encoding immunoglobulin heavy and light chains
during B cell development, from a pre-existing library of variable gene segments, results in each B
cell expressing a unique immunoglobulin specificity. Immunoglobulin diversity is further refined
by somatic mutation of the immunoglobulin genes during development of an immune response,
which enables selection of B cells expressing antibodies with enhanced affinity for the immunogen.
Studies of immunoglobulins in domestic animal species have highlighted certain unique features.
One such example is that Camelids produce a subset of immunoglobulins composed only of a
heavy chain, in which antigen recognition involves only one variable region. This has allowed
isolation of these single heavy chains and their expression as recombinant antibodies, referred
to as nanobodies, for various practical applications (1). Compared to humans and mice, cattle
and sheep have a more restricted repertoire of immunoglobulin variable gene segments, but
they compensate for this by utilizing antigen-independent somatic mutation of their rearranged
immunoglobulin genes to generate further sequence diversity. Another distinct feature in cattle is
that ∼10–15% of immunoglobulins possess an ultralong heavy chain CDR3 domain. In contrast
to conventional antibodies where antigen recognition involves interaction with six hypervariable
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loops (or complementarity determining regions–CDRs)–three
on the heavy chain and three on the light chain—recognition
of antigen by these ultralong antibodies is determined
predominantly by the HCDR3, which has an extended stalk-knob
like structure (2–5).
The capacity to analyse antibody responses against infectious
agents at the single B cell level provides a powerful means
to identify the biological properties of individual antibody
specificities, including their potential role in immunity. Until
recently, such analyses have proved difficult in outbred species.
Techniques developed in the 1970s for generating monoclonal
antibodies in mice and rats were not readily applicable to other
species, because of the absence of suitable myeloma cell lines
for use as fusion partners. Attempts to use murine myeloma cell
lines with bovine B cells to generate heterohybridomas had some
success in producing bovine monoclonal antibodies, but these
systems were not sufficiently efficient to allow their routine use
(6–8). A further factor that constrained the ability to analyse
antibody responses at the clonal level was the limited capacity of
antibody-producing cells to proliferate, as they undergo terminal
differentiation as plasma cells. This is in marked contrast to
antigen-specific T cells, which can be propagated and cloned
in vitro, allowing analyses of their specificity at the clonal
level. In the last few years, advances in the sensitivity of
methods to examine gene expression at the single cell level
have opened up new opportunities to analyse B cell responses,
including the isolation of expressed immunoglobulin genes from
individual B cells.
This paper aims to provide a brief review of new and emerging
approaches to interrogating bovine antibody responses, focusing
particularly on analyses of responses at the single B cell level.
ADVANCES IN CLONAL ANALYSES OF
ANTIBODY RESPONSES IN OUTBRED
SPECIES
In the last few years, methods have been established for
generating antigen-specific human monoclonal antibodies from
B cells isolated ex vivo from humans mounting an antibody
response. These methods are based on the ability to enrich
for specifically reactive B cells and the capacity to isolate and
express immunoglobulin genes from single responding B cells.
Enrichment for antigen-specific B cells has relied either on
use of fluorescently labeled antigen tetramers to identify and
isolate antigen-specific B cells or isolation of plasmablasts and
plasma cells using surface markers expressed specifically on
these activated B cell populations. Rapid methods for isolation
and expression of immunoglobulin heavy and light chain genes
from single B cells have allowed analyses of the antibody
specificities. Such approaches have proved to be highly successful
in generating novel data on the fine specificity of human antibody
responses to a number of pathogens, most notably influenza and
Ebola viruses (9, 10).
The ability to conduct similar analyses of antibody responses
in cattle would represent a major advance, particularly with
respect to identification of antibody targets for use in vaccination.
Many pathogens induce antibody responses to multiple antigens,
only some of which play an important role in immune protection.
The capacity to screen the biological activities of monoclonal
antibodies induced in the target species, provides a direct means
of identifying antigens that are likely to be immunogenic. In some
diseases, immune responses are dominated by antibodies against
antigens that vary between pathogen strains, leading to strain-
specific immunity (e.g., foot and mouth disease virus). In such
cases, interrogation of the fine specificity of the response at the
clonal level, offers the means of identifying subdominant cross-
reactive antigenic specificities with potential for vaccination.
REAGENTS FOR STUDYING B CELL
RESPONSES IN CATTLE
The ability to apply these new technologies to studies of bovine
B cell responses has been constrained by a paucity of reagents
for studying B cell differentiation. Studies of human B cell
responses are able to utilize a suite of reagents developed against
surface markers, which enables relatively precise characterization
and placement of B cells within the differentiation cascade.
Identification of particular stages of differentiation frequently
relies on the use of combinations of several markers, and in some
instances consideration of their levels of expression.
Two distinct lineages of B cells, B-1 and B-2, have been
identified in humans and mice. In contrast to conventional B-2
cells, which cooperate with helper T cells and undergo Ig isotype
switching and affinity maturation within germinal centers, B-1 B
cells have minimal requirement for auxiliary signals and respond
rapidly by producing predominantly IgM (11, 12). The majority
of B-1 cells are CD5+ (referred to as the B-1a subset), with a
minor subset being CD5− (B-1b subset). In cattle, expression
of surface CD5 has been used as a marker for B-1a B cells,
which represent ∼20–25% of B cells in PBMC (13). CD5+ B
cells play a prominent role in bovine immune responses to a
number of pathogens, including Trypanosoma congolense (14),
foot and mouth disease virus (15) and Bovine Leukosis Virus
(16). In the case of T. congolense, the percentage of CD5+ B cells
in peripheral blood approximately doubles during the first 3–4
weeks of infection.
Of greater relevance to the present discussion are B-2 B cells,
which undergo a complex series of differentiation events during
generation of an antibody response. Interaction of mature-
naïve B cells with antigen via the B cell receptor (BCR), which
is associated with a complex of proteins (CD19, CD21 and
CD79) that are responsible for co-stimulation, promotes B cell
activation and differentiation (17, 18). Multiple changes in cell
surface phenotype occur once the B cells have been activated,
including increased levels of CD40, CD69, CD80 and CD86. Up-
regulation of CD40, coupled with antigen uptake by specific B
cells, enables them to interact with antigen-specific T cells in
the follicles of secondary lymphoid organs, leading to germinal
center formation and further B cell differentiation, including Ig
isotype switching and affinity maturation. The latter involves a
clonal selection process, in which antigen-specific B cells with
the highest affinity are selected for survival and clonal expansion.
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Finally, B cells either differentiate into long-lived memory cells
or develop to plasmablasts and antibody-secreting plasma cells.
Increased expression of surface CD27 is an important marker for
memory cells, although they show considerable heterogeneity in
phenotype and function (19, 20). Among the phenotypic changes
that occur during differentiation to plasma cells is increased
levels of expression of CD38, which is frequently exploited for
identifying antibody-secreting cells (21).
In contrast to human B cells, there is a distinct lack of antibody
reagents that enable discrimination between the different states
of differentiation of B-2 B cells in cattle. Apart from surface
immunoglobulin and CD21, there are no well-defined pan-
B cell markers in cattle. Although IgD is used as one of
the surface markers of naive human B cells, its existence in
cattle was only demonstrated in 2006 (22) and there is only
one report of expression of the protein on a minor subset of
bovine B cells (23). There are also no monoclonal antibody
reagents that can be used to identify plasmablasts and plasma
cells. Similarly, memory B cell markers are not well-developed
for cattle. Therefore, the ability to resolve and understand the
intricacies of the bovine B cell response is substantially hampered
at present, and requires investment to generate the tools required
to fill this gap; this is starting to be addressed by initiatives
such as the Veterinary Immunological Toolbox (https://www.
immunologicaltoolbox.co.uk/).
GENOMIC ORGANIZATION OF
IMMUNOGLOBULIN GENES IN THE COW
AND DIVERSITY GENERATION
It is now known that bovine B cells express five isotypes
of immunoglobulin: IgM, IgD, IgG, IgE and IgA, with the
IgG isotype differentiated into three sub-isotypes (IgG1, IgG2
and IgG3), and IgM into two sub-isotypes (24, 25). Until
relatively recently, annotation of the bovine heavy and light
chain genomic loci was incomplete. Of the genes that encode
the immunoglobulin antigen binding domains [heavy and light
chain variable (V), diversity (D) and joining (J) segments], which
are generated by VDJ recombination, cattle differ substantially
from humans and mice, in particular with respect to the
comparative paucity of variable gene content. Cattle have only
twelve genes encoding functional heavy chain variable gene
segments (IGHV—located on chromosome 21), and all belong
to one subgroup, IGHV1 (compared to seven diverse subgroups
in humans), with a number of pseudogenes also described in
both IGHV1 and two further subgroups, IGHV2 and IGHV3.
Only four of the twelve documented heavy chain joining gene
segments (IGHJ) and sixteen of the twenty-three diversity gene
segments (IGHD) found in cattle appear to be functional (25).
Additionally, compared with humans and mice, available data
suggest that cattle have a more restricted set of putatively
functional light chain genes (26). Most vertebrates express two
light chain isotypes: kappa (κ) and lambda (λ). However, the
bovine light chain repertoire is dominated by the expression
of λ genes [κ usage represents ∼5% of the expressed antibody
repertoire (27)], and predominantly by one subfamily, Vλ1.
Vλ genes are clustered close to the Jλ and Cλ cluster on
chromosome 17 (28) and Vκ genes on chromosome 11 (26).
In cattle, the limited data available suggest the light chain may
have a subsidiary role in antigen recognition, with most antigen
binding being driven by the heavy chain variable region. Recent
x-ray crystallography data on the structure of two bovine IgG
antibodies support this assertion by showing that the heavy
chain predominantly contributes to the antigen-combining site
(29, 30). When the light chains were exchanged between these
two antibodies, antigen recognition by one of the antibodies
(but not the other) was substantially reduced and structurally
this was associated with a subtle change in the orientation
of the associated heavy chain. An earlier study of a poly-
specific IgM long-CDR3 antibody had also demonstrated a
predominant role of the heavy chain in antigen recognition,
although interaction with some antigenic ligands was influenced
by the light chain (29).
The information on the genomic architecture of the bovine
immunoglobulin loci has been derived from work on European
Bos taurus breeds, with the most complete genome assembly
and associated resources deriving from a Hereford cow (31–
34). Immune gene loci tend to be highly repetitive by nature,
and therefore difficult to accurately assemble without the use of
resource-intensive sequencing technologies that enable accurate
construction across large stretches of multiple and similar
gene members—for example, long-read or chromatin-linking
sequencing approaches. While such genomic resources are being
developed for other breeds [e.g., Brahman Bos indicus (35)],
there are still too few genomes sequenced to a sufficient depth
across diverse cattle breeds and lineages to enable assessment of
the degree of immunoglobulin locus polymorphism, and how
that may impact upon antibody expression and function. This
is the focus of increasing effort (e.g., the Bovine Pan Genome
Consortium), and increasing the genomic resources across breeds
and lineages will be important in functionally linking genomic
diversity to phenotypic diversity with respect to the bovine
antibody response.
The limited repertoire of germline variable gene segments
in cattle has been proposed to be offset by the occurrence of
somatic hypermutation in rearranged B cells prior to exposure
to antigen, thus generating greater diversity and expanding the
B cell repertoire (36, 37). There is evidence from studies in
both sheep and cattle (36, 38) that the ileal Peyer’s patch is a
major site of this antigen-independent somatic mutation. This
organ, which differs histologically from conventional Peyer’s
patches, develops with the kinetics of a primary lymphoid
organ (i.e., similar to the thymus). In sheep, the ileal Peyer’s
patch undergoes significant development during the latter
half of gestation, with further enlargement in the first few
months of life, and gradual involution from about 3 months
onwards (39).
Bovine HCDR3 length on average is longer than in other
vertebrates such as humans or mice (bovine HCDR3 ranging
from <10 to at least 67 amino acids in length, in contrast
to 4–36 amino acids in humans) (2, 5, 22, 24, 40, 41). It
has been known for many years that a proportion (∼10%)
of bovine immunoglobulin transcripts contain unusually long
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HCDR3 domains up to and beyond 60 amino acids long (40,
42–45)—often termed “ultralong” HCDR3 domains. Resolution
of the structure of these antibodies identified an unusual and
relatively conserved stalk-knob protrusion, which comprised
the HCDR3 antigen-binding domain (2, 3, 5). Formation of
the stalk structure is facilitated by the presence of several
disulphide bonds. The ultralong antibodies described thus far
all utilize a single variable gene (IGHV1-7) and diversity gene
(IGHD8-2) donor (2, 41), and the few paired heavy and light
chain data available also suggest utilization of a limited number
of λ light chain V genes (46). Based on analyses of the
sequences of multiple long HCDR3 antibodies, a recent study
by Deiss et al. (41) has identified a number of key features of
the rearranged genes encoding these antibodies. Firstly, they
confirmed the almost exclusive use of the IGHV1-7 gene segment
and showed that this variable gene contains an internal 8-
nucleotide duplication (which contributes to formation of the
elongated stalk structure). They also found that, in contrast
to other IGHV gene rearrangements, the IGHV1-7 CDR1 and
CDR2 regions contain a low frequency of mutations, whereas
the CDR3 regions of the same genes show very high levels of
mutation compared to the germline sequence (41). This relative
conservation of CDR1 and CDR2 sequences is consistent with
evidence that these regions have little involvement in antigen
binding but rather play a structural role in the long HCDR3
antibodies, whereas the knob-like structure formed by the CDR3
region is the primary antigen-binding site. Direct evidence for
the latter was provided by the demonstration that removal of
the “knob” sequence ablated antigen binding by the modified
antibody (2). Deiss et al. also identified an unusually high degree
of deletion events in the HCDR3 domains of long antibodies
(predominantly in the IGHD8-2 segment), including deletions
that alter the reading frame, thus contributing to ediversity in
both the length and sequences of the CDR3 segments and hence
structural diversity of these antibodies (41). They hypothesized
that this may also be mediated by the enzymatic driver of somatic
hypermutation, activation induced cytosine deaminase (AID).
This mechanism has been proposed to be a means of generating
structural diversification through modification of the pattern of
disulfide bond formation (41). This is facilitated by an unusual
codon bias in HCDR3, which predicates mutation to cysteine
(particularly in the IGHD8-2 segment codons) during bovine
VDJ recombination, resulting in the generation of diversity in
structure due to the making and breaking of di-sulfide bonds
between paired/unpaired cysteines (2, 47). This diversification
mechanism has also been shown to operate in conventional
length bovine antibodies (47). Analyses of the sequences of re-
arranged bovine Ig genes has additionally indicated evidence of a
low frequency of gene conversion events in both light and heavy
chains that involves short nucleotide segments from light and
heavy chain pseudogenes (48, 49), potentially providing a further
means of generating sequence diversity–although current data
are limited and its importance has yet to be fully determined.
In summary, the long HCDR3 antibodies exemplify the bovine
host’s adaptations to generating antibody diversity from a limited
germline repertoire–the combination of codon bias and (possible
AID-mediated) targeted deletions resulting in changing of the
pattern of cysteine pairs, generating a remarkable ability to create
structural diversity in epitope-binding domains, despite being
restricted to the use of a single V and D segment.
While the function of these ultralong antibodies remains
unclear [interestingly the proportion of ultralong antibodies
is significantly higher in neonatal calves (50)], their unusual
structure quickly raised the hypothesis that such antibodies
could bind to antigen epitopes that were not accessible to
conventionally structured immunoglobulins. For example, sites
on bacterial pore proteins or proteins embedded within the
complex surface coat of parasitic pathogens, which are hidden
from conventional antibodies, may be potential targets. There
has also been significant interest in application of ultralong
antibodies to non-bovine pathogens and their exploitation for
development as potential therapeutics, in particular for human
pathogens such as HIV (46)—the potential for therapeutics of
relevance to veterinary pathogens is also clearly a possibility that
is currently underexploited. However, the exact roles that these
antibodies play during natural immune responses in cattle, or,
for example, whether they may be an important factor in the
efficacy of immune responses induced by vaccines, are unclear.
Additionally, all studies analyzing long HCDR3 antibodies
have examined European Bos taurus cattle—although the long
HCDR3 antibody expression levels been shown to be consistent
across several European B. taurus breeds, current data on, for
example, long HCDR3 antibody expression data in Bos indicus
or African B. taurus breeds, and any role they may play across
the very different infectious disease contexts that such breeds are
exposed to, are all currently unknown. These are all areas that
clearly merit further research.
IN VITRO CULTURE OF ACTIVATED
B CELLS
Although most studies of antibody responses at the single cell
level have focused on analyses of actively responding B cells
harvested ex vivo, in recent years there have been attempts
to analyse the antibody repertoire of memory B cells (51).
Since memory B cells are normally present at low frequencies,
this approach is dependent on use of culture systems to
activate and expand the memory B cells. This in turn requires
precise phenotyping reagents (52). A number of studies have
reported successful establishment of in vitro culture systems
that allow expansion of human memory B cell populations and
differentiation to immunoglobulin secretion (53). These studies
have used combinations of factors that stimulate activation,
proliferation, and differentiation, coupled with inhibition of
apoptosis, of B cells to maintain growth in vitro, albeit for a
limited period of time.
Systems for culturing B cells have attempted to mimic the
events that drive B cell development during antibody responses
in vivo. The stimulation of B cells by crosslinking of the BCR with
anti-IgM antibodies is well-established as a means of mimicking
antigen stimulation (54). Uptake and processing of antigen by
specific B cells enables them to present the antigen to T cells,
which provide co-stimulatory signals by interaction of CD40
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FIGURE 1 | Identification of bovine antigen-specific B cells in peripheral blood mononuclear cells (PBMCs) of an antigen-immunized calf by staining with
Phycoerythrin-labeled antigen tetramers: (A) PBMCs isolated from naïve and immunized calves were stained by two-color immunofluorescence with a monoclonal
antibody (IL-A58) specific for bovine immunoglobulin light chain (IgL) and antigen tetramer. Representative plots of stained cells from a naïve animal (B) and an
immunized animal (C) are presented, showing the presence of an IgL+ Tetramer-Ag+ population in the immunized animal. Approximately 1% of IgL+Tetramer-Ag+
B cells were detected in the immunized calve, compared to <0.2% in the unimmunized control.
on the activated B cells with CD40 ligand (CD40L) on the T
cells. This process can be mimicked in vitro by stimulation of B
cells with soluble CD40L (55, 56). Activation in vitro via CD40
promotes an increase of levels of IL-21 receptor on the B cell
surface (57). Among the cytokines that also contribute to B cell
activation, IL-21, induced by T cells upon interaction with B cells
is a key stimulus for B cell proliferation and differentiation (58).
One of the main surface ligands involved in B cell survival is
the BAFF receptor (BAFFR) that binds BAFF (B cell activating
factor of the TNF family). Other similar related receptors that
bind BAFF, are TACI and BCMA, which can also bind APRIL
(α proliferation-inducing ligand), and these play a key role in
preventing cell death and increasing plasma cell survival (59).
This knowledge has been applied to successfully culture
activated porcine B cells, taking advantage of the cross-reactivity
of the human reagents with porcine B cells (60). Addition of
IL-21 plus CD40L to purified pig B cells resulted in activation
and proliferation over a 4-day period, and inclusion of BAFF
and APRIL maintained the viability of the cells for 7 days.
Secretion of low levels of both IgM and IgG by these cultures
was detected on day 7 of culture indicating differentiation of
some of the activated B cells. The reagents used in this study also
cross-react with bovine B cells and we have been able to obtain
similar activation, proliferation and maintenance of bovine B
cells similar to that reported by Rahe and Murtaugh (60). The
development of phenotyping reagents that allow identification of
bovine memory B cells will enable these culture systems to be
used to amplify memory cell populations prior to clonal analyses
of their specificities.
ISOLATION OF ANTIGEN-SPECIFIC
B CELLS
The isolation of antigen-specific B cells is a critical step in the
ability to evaluate and analyze the bovine humoral immune
response, particularly responses to either specific pathogens or
vaccination. In addition, due to the unique properties of bovine
antibodies as described above, the isolation of antigen-specific
cells is a route to explore their potential relevance as novel
molecular tools for research or therapeutic use.
Populations of human B cells enriched for antibody-
producing cells have been isolated from blood by flow cytometry
using a combination of cell surface markers, including CD19,
CD20, CD38, and CD71 (61). In the absence of such markers
for cattle, the ability of antibody-producing cells to bind
fluorescently labeled tetramerised antigen offers an alternative.
This approach is challenging because of the low frequencies of
antigen-producing B cells in peripheral blood, and the short
time window during which these cells are present at sufficient
frequency for detection by flow cytometry. Moreover, antigen
tetramers do not detect all antibody-producing cells, as mature
plasma cells lose expression of surface Ig upon transition
from plasmablasts (62). We have employed established methods
(63) to produce streptavidin-labeled tetramers incorporating
a recombinant protein from the major cattle pathogen,
Trypanosoma congolense and used these tetramers to monitor the
blood of calves immunized with this antigen. These experiments
revealed the presence of a small population of surface Ig+
tetramer+ cells, detectable for several days after the third dose of
antigen administered in adjuvant (Figure 1). In Giemsa–stained
cytospin preparations the positive cells exhibited a plasmablast
morphology. Further studies are underway to isolate and analyse
the immunoglobulin genes expressed by these B cells.
IMMORTALISATION OF B CELLS BY
INFECTION WITH THEILERIA ANNULATA
One of the potential uses of isolated antigen-specific B cells is to
transform the cells to allow clonal expansion of the populations
and potentially examine antibody secretion. Some species of
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FIGURE 2 | Surface phenotype of five cloned B cell lines infected with Theileria parva, as described by Baldwin et al. (65). Briefly, surface Ig+ B cells (>98% purity)
were isolated by cell sorting from healthy resting peripheral blood mononuclear cells and infected in vitro by incubation with T. parva sporozoites, followed by cloning
at limiting dilution in 96-well round-bottom plates. The cells were phenotyped 8 weeks after infection by staining with monoclonal antibodies specific for bovine IgM
and IgG (Mab B5/4 and IL-A2, respectively) followed by fluorescein-labeled anti-mouse Ig. Significant levels of IgM or IgG expression were detected only on two of the
clones (clone 1–IgM; clone 6–IgG). The percentages of positive gated cells for each clone are (Clone 1: Control−1%, IgM−54%, IgG−6%. Clone 2: Control−3%,
IgM−6%, IgG−6%. Clone 3: Control−2%, IgM−3%, IgG−10%. Clone 5: Control−2, IgM−4%, IgG−4%. Clone 6: Control 5%, IgM−2%, IgG−47%). Controls were
incubated with secondary antibody only. All clones were negative for T cell markers (CD2, CD4, CD8)–data not shown.
Theileria parasites are able to infect and transform bovine
lymphocytes. Theileria are tick-borne apicomplexan protozoa
found in tropical and subtropical regions of the world. The
most important species in cattle are Theileria annulata and
Theileria parva (64). Both species infect leukocytes: T. parva
infects T and B lymphocytes, while T. annulata infects monocytes
and B cells (65, 66). A characteristic feature of infection with
both parasites is that they induce activation and proliferation
of the cells they infect (67), during which the parasites divide
synchronously with the host cells (68). This relationship, coupled
with inhibition of apoptosis of the host cells by the parasite
(69) results in clonal expansion of the cells initially infected
by the parasite. These properties enable the infected cells to be
maintained as continuously growing cell lines in vitro, and such
cell lines can be initiated by in vitro infection of leukocytes with
the tick-derived infective stage of the parasite, the sporozoite.
In previous studies, we examined the phenotype of purified
resting Ig+ B cells several weeks after infection in vitro with T.
parva. Most infected cells were found to gradually lose surface
expression of immunoglobulin, although analyses of cloned
populations revealed continued Ig expression, either IgM or
IgG, by some clones (70) (Figure 2). Similar gradual loss of
Ig expression has also been observed in B cells infected with
T. annulata. However, expression of Ig by B cells in the early
stages after infection by Theileria was not studied, nor was the
susceptibility of activated B cells to infection examined in these
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experiments. In recent studies, we have shown that purified
tetramer+ B cells are similarly susceptible to infection with T.
annulata. However, similar to previous findings with infected
resting B cells, following cloning and expansion of the cloned
populations over a 3–4 week period, only a subset of the clones
secreted antibody.
These preliminary finding suggest that this system could be
used to obtain cells secreting antibody with particular antigenic
specificities, but may not be suitable for direct large-scale clonal
analyses of antibody responses at the level of Ig secretion.
Nevertheless, the generation of cloned transformed B cells from
antigen-specific B cells could prove to be a valuable resource of
immortalized cells from which the rearranged Ig heavy and light
chain pairs can be retrieved for further analyses. However, further
studies are required to explore the full potential of this system.
IMMUNOGLOBULIN GENES EXPRESSED
BY SINGLE B CELLS
While advances have been made in our understanding of the
genomic repertoire of bovine immunoglobulin loci, we still
have only limited data on the usage of these gene families in
generating functional, effective antibody proteins. This partly
stems from the difficulty in deconvoluting data generated from
cell pools or populations into that relevant at the single cell
level—this is in most cases an insurmountable bioinformatic
challenge, whether short or long read sequencing approaches
are used. An obvious route to gaining data at this level is
to analyse gene expression of multiple single cells, rather
than averaging gene expression across RNA extracted from
populations. There are several factors required to do this—one
being an ability (within the context of a response to a particular
immunogen) to identify and isolate multiple single antigen
specific cells (current limitations and challenges around this
are outlined above). Despite this challenge, data on single cells,
yielding paired heavy and light chain sequences, are emerging
in bovine studies, although still only from small numbers
of cells.
The ability to analyse single cell data at scale from humans
has significantly advanced in recent years. Single cells can be
isolated by various routes [micro-dissection, flow cytometry,
microfluidics and droplet-based methods (71)], each of which
have their advantages and limitations. Droplet-based methods
in particular have led to a step change in terms of scale,
providing the ability to potentially analyse thousands of single
cells (72–74). The challenge of analyzing the VH and VL
sequences of B cells has been to some extent overcome in
human studies by isolating single cells within emulsion droplets,
in which the cells are lysed and mRNA captured by poly-
dT beads. From this substrate physically linked VH and VL
transcripts are generated through overlap-extension reverse-
transcription PCR (OE RT-PCR), effectively splicing the VH
and VL amplicons together, which can then be resolved into
paired VH and VL chain data (75). This has resulted in
novel insights in terms of VL and VH pairing and use,
and the identification of broadly virus neutralizing antibodies
(76). However, while providing a substantial improvement on
individual VH and VL PCRs from isolated cells, the OE RT-
PCR approach is still technically indirect, with the full-length
variable sequence inferred from assembly of several partial
sequences because of the limitations of sequencing technologies.
A recent development, termed sc-BCRseq, applied barcodes to
fragmented VH and VL sequences from single B cells within
droplets, importantly then providing confident downstream
assembly into full length paired VH and VL sequences (77).
This approach also can be employed in a high throughput
manner, and was successfully applied to 250,000 B cells and
enabled high resolution analysis of antibody lineages in response
to immunization (77). All of these approaches still have their
challenges, one particular issue with B cells (if an aim is
to analyse antibody response development through the B
cell lineage) being sensitivity bias—the increased Ig transcript
levels in plasmablasts meaning they are over-represented in
expression data.
While the advances in single cell technologies present exciting
future possibilities when applied to the bovine antibody response,
in the context of analyzing antibody responses to a specific
antigen, the initial step in identifying and isolating antigen-
specific B cells is still necessary. Thus, the generation of B cell
reagents that allow more precise analysis of single cells remains a
priority in order to fully realize our ability to analyse the antibody
response in cattle.
SUMMARY AND CONCLUSIONS
Our understanding of the bovine B cell and antibody response
has advanced significantly in recent years, with genomic and
experimental data resolving the unique manner in which the
cow generates immunoglobulin diversity from a restricted
germline VH repertoire. This has included the characterization
of ultralong HCDR3 domain antibodies and their structure,
and consequent interest in their potential application to novel
therapeutics. However, our ability to advance understanding
of many aspects of the antibody response is restricted by
a lack of reagents for bovine B cells, in particular those
that allow identification and characterization of B cells at
different stages of differentiation along the B cell lineage. Such
tools would enable more detailed analysis of the initiation,
progression and maturation of an effective antibody response,
as well as the ability to address specific questions such as the
role of HCDR3 antibodies during infection or in response to
vaccination. The ability to isolate antigen-specific B cells is also
key to facilitating analyses within the context of infection or
vaccination, and we have outlined potential routes to how this
could be achieved–the development of better reagents for bovine
plasma cells/plasmablasts would certainly significantly enhance
this capability. Finally, application of single cell sequencing
technologies has the potential to revolutionize the analysis of B
cell responses, enabling the isolation of paired heavy and light
chain data from hundreds of thousands of B cells. Therefore,
with investment in the development of key reagents combined
with single cell sequencing at scale, we are poised to enter
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an era that can transform our understanding of the bovine
antibody response.
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